h for health 32

Micrographs present the distinction between handled and untreated bone cells in a mouse mannequin of extreme bone loss. Wisconsin researchers have recognized two native protein components that assist maintain mesenchymal stem cells -- the grasp cells that make bone and cartilage -- comfortable within the laboratory dish. The work may in the future assist make regenerating misplaced bone in sufferers a actuality. Credit score: Wan-Ju Li The prospect of regenerating bone misplaced to most cancers or trauma is a step nearer to the clinic as College of Wisconsin-Madison scientists have recognized two proteins present in bone marrow as key regulators of the grasp cells answerable for making new bone. In a examine printed on-line within the journal  Stem Cell Studies , a workforce of UW-Madison scientists stories that the proteins govern the exercise of mesenchymal stem cells -- precursor cells present in marrow that make bone and ca...

MDS is caused by a deletion of a section of human chromosome 17 containing genes important for neural development. The result is a brain whose outer layer, the neocortex, which is normally folded and furrowed to fit more brain into a limited skull, instead has a smooth appearance (lissencephaly) and is often smaller than normal (microcephaly). The disease is accompanied by severe seizures and intellectual disabilities, and few infants born with MDS survive beyond childhood. In the new study -- published online January 19, 2017 in  Cell Stem Cell  -- the research team transformed skin cells from MDS patients and normal adults into neural stem cells, which they placed in a 3 dimensional culture system to grow organoid models of the human neocortex with and without the genetic defect that causes MDS. Closely observing the development of these MDS organoids over time revealed that many neural stem cells die off at early stages of development, and others exhibit defects in c...

Despite its immense promise, adoption of iPSCs in biomedical research and medicine has been slowed by concerns that these cells are prone to increased numbers of genetic mutations. A new study by scientists at the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, suggests that iPSCs do not develop more mutations than cells that are duplicated by subcloning. Subcloning is a technique where single cells are cultured individually and then grown into a cell line. The technique is similar to the iPSC except the subcloned cells are not treated with the reprogramming factors which were thought to cause mutations. The researchers published their findings on February 6, 2017, in the  Proceedings of the National Academy of Sciences . "This technology will eventually change how doctors treat diseases. These findings suggest that the question of safety shouldn't impede research using iPSC," said Pu Paul Liu, M.D., Ph.D., co-author, se...